Synta Pharmaceuticals cut 90 jobs, nearly 40% of its workforce, citing the recent suspension of its cancer drug trial.
Late-stage trial of the drug, elesclomol, was suspended last month after an independent data monitoring committee observed a higher number of deaths and other safety concerns.
The Lexington, Massachusetts-based company says the restructuring will allow the company to operate for the next two years without additional equity financing.
INTERESTED IN IMPROVING YOUR CAREER? CHECK OUT …
|
THE CAREER TRANSFORMATION SYSTEM TM SIGN UP NOW! |
Resources
Search Jobs
Post Your Resume to 65+ Job Sites
Resume Service
Leave a Reply
You must be logged in to post a comment.